325 related articles for article (PubMed ID: 28081641)
1. Vessel pruning or healing: endothelial metabolism as a novel target?
Cantelmo AR; Pircher A; Kalucka J; Carmeliet P
Expert Opin Ther Targets; 2017 Mar; 21(3):239-247. PubMed ID: 28081641
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Ramjiawan RR; Griffioen AW; Duda DG
Angiogenesis; 2017 May; 20(2):185-204. PubMed ID: 28361267
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.
Jain RK
Cancer Cell; 2014 Nov; 26(5):605-22. PubMed ID: 25517747
[TBL] [Abstract][Full Text] [Related]
4. Pathological angiogenesis: mechanisms and therapeutic strategies.
Dudley AC; Griffioen AW
Angiogenesis; 2023 Aug; 26(3):313-347. PubMed ID: 37060495
[TBL] [Abstract][Full Text] [Related]
5. Alternative Strategies to Inhibit Tumor Vascularization.
Brossa A; Buono L; Fallo S; Fiorio Pla A; Munaron L; Bussolati B
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817884
[TBL] [Abstract][Full Text] [Related]
6. Tumor Vessel Normalization: A Window to Enhancing Cancer Immunotherapy.
Li S; Zhang Q; Hong Y
Technol Cancer Res Treat; 2020; 19():1533033820980116. PubMed ID: 33287656
[TBL] [Abstract][Full Text] [Related]
7. Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy.
Choi Y; Jung K
Exp Mol Med; 2023 Nov; 55(11):2308-2319. PubMed ID: 37907742
[TBL] [Abstract][Full Text] [Related]
8. Combining microenvironment normalization strategies to improve cancer immunotherapy.
Mpekris F; Voutouri C; Baish JW; Duda DG; Munn LL; Stylianopoulos T; Jain RK
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3728-3737. PubMed ID: 32015113
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel in vitro human tissue-based angiogenesis assay to evaluate the effect of antiangiogenic drugs.
Woltering EA; Lewis JM; Maxwell PJ; Frey DJ; Wang YZ; Rothermel J; Anthony CT; Balster DA; O'Leary JP; Harrison LH
Ann Surg; 2003 Jun; 237(6):790-8; discussion 798-800. PubMed ID: 12796575
[TBL] [Abstract][Full Text] [Related]
10. Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization.
Nikmaneshi MR; Jain RK; Munn LL
PLoS Comput Biol; 2023 Jun; 19(6):e1011131. PubMed ID: 37289729
[TBL] [Abstract][Full Text] [Related]
11. A patent perspective of antiangiogenic agents.
Zhang J; Wang J; Li Y; Pan X; Qu J; Zhang J
Expert Opin Ther Pat; 2023 Dec; 33(12):821-840. PubMed ID: 38084667
[TBL] [Abstract][Full Text] [Related]
12. Oncogenes and angiogenesis: a way to personalize anti-angiogenic therapy?
Bottos A; Bardelli A
Cell Mol Life Sci; 2013 Nov; 70(21):4131-40. PubMed ID: 23685900
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment.
Jasim SA; Farber IM; Noraldeen SAM; Bansal P; Alsaab HO; Abdullaev B; Alkhafaji AT; Alawadi AH; Hamzah HF; Mohammed BA
Microvasc Res; 2024 Jul; 154():104691. PubMed ID: 38703993
[TBL] [Abstract][Full Text] [Related]
14. Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example.
Corti A; Curnis F; Rossoni G; Marcucci F; Gregorc V
BioDrugs; 2013 Dec; 27(6):591-603. PubMed ID: 23743670
[TBL] [Abstract][Full Text] [Related]
15. Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives.
Gacche RN
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189020. PubMed ID: 37951481
[TBL] [Abstract][Full Text] [Related]
16. Targeting Inflammation to Improve Tumor Drug Delivery.
Gkretsi V; Zacharia LC; Stylianopoulos T
Trends Cancer; 2017 Sep; 3(9):621-630. PubMed ID: 28867166
[TBL] [Abstract][Full Text] [Related]
17. Disturbed endothelial cell signaling in tumor progression and therapy resistance.
Fischer A; Alsina-Sanchis E
Curr Opin Cell Biol; 2024 Feb; 86():102287. PubMed ID: 38029706
[TBL] [Abstract][Full Text] [Related]
18. Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?
Wagner SC; Ichim TE; Ma H; Szymanski J; Perez JA; Lopez J; Bogin V; Patel AN; Marincola FM; Kesari S
J Transl Med; 2015 Oct; 13():340. PubMed ID: 26510973
[TBL] [Abstract][Full Text] [Related]
19. The Solid Mechanics of Cancer and Strategies for Improved Therapy.
Stylianopoulos T
J Biomech Eng; 2017 Feb; 139(2):. PubMed ID: 27760260
[TBL] [Abstract][Full Text] [Related]
20. Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy.
Schadler KL; Thomas NJ; Galie PA; Bhang DH; Roby KC; Addai P; Till JE; Sturgeon K; Zaslavsky A; Chen CS; Ryeom S
Oncotarget; 2016 Oct; 7(40):65429-65440. PubMed ID: 27589843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
